Pyridinecarboxylic Acid Derivative Stimulates Pro-Angiogenic Mediators by PI3K/AKT/mTOR and Inhibits Reactive Nitrogen and Oxygen Species and NF-κB Activation Through a PPARγ-Dependent Pathway in T. cruzi-Infected Macrophages
Open Access
- 9 January 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 2955
Abstract
Chagas disease is caused by Trypanosoma cruzi infection and represents an important public health concern in Latin America. Macrophages are one of the main infiltrating leukocytes in response to infection. Parasite persistence could trigger a sustained activation of these cells, contributing to the damage observed in this pathology, particularly in the heart. HP24, a pyridinecarboxylic acid derivative, is a new PPARγ ligand that exerts anti-inflammatory and pro-angiogenic effects. The aim of this work was to deepen the study of the mechanisms involved in the pro-angiogenic and anti-inflammatory effects of HP24 in T. cruzi-infected macrophages, which have not yet been elucidated. We show for the first time that HP24 increases expression of VEGF-A and eNOS through PI3K/AKT/mTOR and PPARγ pathways and that HP24 inhibits iNOS expression and NO release, a pro-inflammatory mediator, through PPARγ-dependent mechanisms. Furthermore, this study shows that HP24 modulates H2O2 production in a PPARγ-dependent manner. It is also demonstrated that this new PPARγ ligand inhibits the NF-κB pathway. HP24 inhibits IKK phosphorylation and IκB-α degradation, as well as p65 translocation to the nucleus in a PPARγ-dependent manner. In Chagas disease, both the sustained increment in pro-inflammatory mediators and microvascular abnormalities are crucial aspects for the generation of cardiac damage. Elucidating the mechanism of action of new PPARγ ligands is highly attractive, given the fact that it can be used as an adjuvant therapy, particularly in the case of Chagas disease in which inflammation and tissue remodeling play an important role in the pathophysiology of this disease.Keywords
Funding Information
- Universidad de Buenos Aires
- Agencia Nacional de Promoción Científica y Tecnológica
This publication has 62 references indexed in Scilit:
- Immune-endocrine interactions related to a high risk of infections in chronic metabolic diseases: The role of PPAR gammaEuropean Journal of Pharmacology, 2019
- Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite ControlFrontiers in Microbiology, 2018
- Cardiomyocyte diffusible redox mediators controlTrypanosoma cruziinfection: role of parasite mitochondrial iron superoxide dismutaseBiochemical Journal, 2018
- New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular DiseasesFrontiers in Immunology, 2018
- Inflammatory Cardiomyopathic SyndromesCirculation Research, 2017
- Cardiomyocyte oxidants production may signal to T. cruzi intracellular developmentPLOS Neglected Tropical Diseases, 2017
- Role of Metabolic H2O2 GenerationJournal of Biological Chemistry, 2014
- Oxidative stress fuels Trypanosoma cruzi infection in miceJournal of Clinical Investigation, 2012
- Chagas diseaseThe Lancet, 2010
- Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infectionJournal of Cellular and Molecular Medicine, 2009